scholarly article | Q13442814 |
P2093 | author name string | Uday B Kompella | |
Harriet Davidson | |||
Dolores Takemoto | |||
Micheal E Barnett | |||
Yun Mo | |||
P2860 | cites work | Expression of superoxide dismutase in whole lens prevents cataract formation | Q24293031 |
Synthetic DNA delivery systems | Q28142096 | ||
Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung | Q28366239 | ||
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration | Q28590177 | ||
Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors | Q29620194 | ||
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. | Q33202530 | ||
The role of oxidative stress in the pathogenesis of age-related macular degeneration. | Q34060719 | ||
Nonviral gene therapy and its delivery systems | Q34324591 | ||
Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins | Q34336609 | ||
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. | Q34702948 | ||
Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration | Q35084405 | ||
The retina: oxidative stress and diabetes | Q35576292 | ||
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences | Q35677091 | ||
Age-related nuclear cataract-oxidation is the key. | Q36111043 | ||
Periocular routes for retinal drug delivery | Q36316631 | ||
Oxygen and retinopathy of prematurity | Q36398131 | ||
Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery | Q36409586 | ||
Structure and ligand binding properties of human serum albumin | Q37873920 | ||
Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. | Q38519496 | ||
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids | Q40391286 | ||
Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells | Q40395997 | ||
Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells | Q40404364 | ||
Transfection efficiency and uptake process of polyplexes in human lung endothelial cells: a comparative study in non-polarized and polarized cells. | Q40448238 | ||
Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery. | Q40463212 | ||
Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier | Q40542430 | ||
Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide. | Q40606065 | ||
Human serum albumin-polyethylenimine nanoparticles for gene delivery | Q40633583 | ||
Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression | Q41035885 | ||
High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors. | Q41560398 | ||
Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells | Q42867898 | ||
Chitosan microparticles containing plasmid DNA as potential oral gene delivery system | Q46781091 | ||
In vivo passage of albumin from the aqueous humor into the lens. | Q47791826 | ||
Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide). | Q51300154 | ||
Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. | Q51758042 | ||
Albumin nanoparticles as carriers for a phosphodiester oligonucleotide | Q74693408 | ||
Oxidative stress in Adamantiades-Behçet's disease | Q77748260 | ||
Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis | Q80219462 | ||
Lipid transfer between cationic vesicles and lipid-DNA lipoplexes: effect of serum | Q80349323 | ||
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 746-757 | |
P577 | publication date | 2007-05-23 | |
P1433 | published in | Molecular Vision | Q6895981 |
P1476 | title | Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene | |
P478 | volume | 13 |
Q37786424 | Applications of nanoparticles in ophthalmology |
Q55024462 | Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics. |
Q37676230 | Correction of Monogenic and Common Retinal Disorders with Gene Therapy |
Q61811208 | Drug Exchange between Albumin Nanoparticles and Erythrocyte Membranes |
Q30478379 | Drug delivery to the posterior segment of the eye for pharmacologic therapy |
Q30459643 | Gene therapy in the cornea: 2005--present |
Q37399016 | Influence of dosage form on the intravitreal pharmacokinetics of diclofenac |
Q41442716 | Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. |
Q33380235 | Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina |
Q42273522 | Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells |
Q37241328 | Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice |
Q38282885 | Nanocarriers of nanotechnology in retinal diseases |
Q38100561 | Nanomedicines for back of the eye drug delivery, gene delivery, and imaging |
Q35843512 | Nanoparticle-based technologies for retinal gene therapy |
Q36396201 | Nanoparticle-motivated gene delivery for ophthalmic application |
Q38119238 | Nanoparticles in the ocular drug delivery |
Q36425890 | Non-viral therapeutic approaches to ocular diseases: An overview and future directions |
Q62002029 | Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy |
Q38063860 | Ocular Drug Delivery; Impact of in vitro Cell Culture Models |
Q92140652 | Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability |
Q37415842 | Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium |